Yesterday I wrote about the revelation that Johns Hopkins will be partnering with Sephora to develop a "Johns Hopkins tested" cosmetics line. Apparently I wasn't the only one uncomfortable with this announcement, as Hopkins retreated from the partnership today (again, via Health Care Renewal):
After the relationship was publicized and criticized, the Baltimore Sun reported that Johns Hopkins quickly decided to revise it. Johns Hopkins will no longer receive stock or a seat on the board of directors of the cosmetics company. Hopkins asked that company marketers "withdraw all references to JHM (Johns Hopkins Medicine) except for certain limited information - on product packages and in previously printed promotional material - that disclose JHM's consulting role," although so far the Sephora web-site's page for Klinger Advanced Aesthetics Cosmedicine has not been modified (as of April 10, 2006).
I'm with Roy Poses; Hopkins' retraction is a good move.